BiomX raises $12M in combined offerings; funds BX004 Phase 2b to Q1 2026

BiomX Inc.

Gross proceeds ~$12M from registered direct offering, private placement, and warrant exercise at $0.9306/share.
Investors include Deerfield Management, Cystic Fibrosis Foundation, and Nantahala Capital.
Proceeds to fund BX004 Phase 2b in CF; topline results expected Q1 2026.
Existing warrants reduced from $2.311 to $0.9306; new warrants issued for 100% of exercised shares.
Also advancing BX211 Phase 2 readout in diabetic foot osteomyelitis this quarter.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-017728
form_type: 8-K
ticker: PHGE
cik: 0001739174
company_name: BiomX Inc.
filed_at: 2025-02-27T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.674755+00:00
generated_at: 2026-05-26T02:21:17.782464+00:00
sec_items: ["1.01", "3.02", "7.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-017728
json_url: https://secwatch.observer/filing/0001213900-25-017728.json
markdown_url: https://secwatch.observer/filing/0001213900-25-017728.md
text_url: https://secwatch.observer/filing/0001213900-25-017728.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390025017728/0001213900-25-017728-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390025017728/ea0232201-8k_biomx.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

OPTU

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 1.01, 3.02, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 1.01, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 1.01, 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CSR

Centerspace approves $240-245M asset sales; exits Bismarck and Rapid City

CENTERSPACE June 1, 2026, 4:30 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AIRJ

AirJoule Technologies raises $15M in registered direct offering at $4.10/share

AirJoule Technologies Corp. June 1, 2026, 8:34 AM ET other_material Items 1.01, 5.07, 7.01, 9.01

same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NXTC

NextCure Phase 1 SIM0505 data: 55% ORR in gynecologic cancers; cash into Q1 2027

NextCure, Inc. June 1, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-25-017728

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.